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INTRODUCTION
Preeclampsia is a pregnancy specific syndrome, char-
acterized by decreased perfusion of secondary organs
and generalized vasospasm. It is a cause of maternal
and fetal morbidity as wel as mortality, with an inci-
dence of 5-8% of all pregnancies.1 Success of preg-
nancy is determined by the formation of a fetal-
maternal complex, in this case, placentation process.2
Abnormalities of placental implantation will lead to
a series of processes due to an increase of free radi-
cals, inflammatory mediators, and an imbalance of
pro and antiangiogenic factors that will lead to endo-
thelial dysfunction.3
Abstract
Objectives: To assess the role of retinol supplementation in the
process of angiogenesis in preeclampsia.
Methods: The research was a double blind randomized clinical
trial conducted Dr. Cipto Mangunkusumo Hospital outpatient clinic
since January 2009 - December 2010. Samples were analyzed in
Prodia Laboratory and Showa University in Tokyo, Japan. Subjects
were tested in trimester 1, 2 and 2 weeks after delivery. During
pregnancy subjects were given pregnancy milk supplements avail-
able on the market which had and that has been retinol fortified. Bi-
variate and multivariate analysis were performed of which retinol
milk feeding, retinol binding protein (RBP) level, and level of
angiogenic factors as independent variables and preeclampsia acted
as the dependent one.
Results: One hundred four study subjects were divided into a
control group of 55 and treatment of 49. Incidence of preeclampsia
in this study was is 8.7% from which 8 persons (14.5%) came from
the control group and 1 person (2%) from the treatment group. Char-
acteristics of the two groups were equivalent. RBP levels obtained
in the treatment group was lower than the control group, while in
the subjects with preeclampsia the RBP level was higher than the
group without preeclampsia. Correlation between the level of RBP
with angiogenic factors showed no significant relationship except
for the level of PlGF (p=0.036) which had a weak correlation
(r=0.206). The level of angiogenic factors in the treatment group
showed lower result than the control group whereas among the sub-
jects with preeclampsia angiogenic factor levels were always higher
than without preeclampsia. With multivariate analysis we found that
significant factors associated with preeclampsia was sFlt-1 levels
(p=0.004) and sFlt-1/PlGF ratio (p=0.017).
Conclusions: Providing milk supplements can reduce the levels
of retinol (RBP), and antiangiogenic factors, but does not signifi-
cantly increase proangiogenic factor level. Assuming there is no
problem with the process of angiogenesis provision of retinol-forti-
fied milk can reduce the incidence of preeclampsia. However, fur-
ther research with a larger scale is needed.
[Indones J Obstet Gynecol 2011; 35-3:100-4]
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Abstrak
Tujuan: Menilai peran suplementasi retinol terhadap proses
angiogenesis pada preeklampsia.
Metode: Penelitian ini merupakan uji klinis dengan disain acak
tersamar ganda, dilakukan di RS Dr. Cipto Mangunkusumo Jakarta
sejak Januari 2009 - Desember 2010. Dilakukan pemeriksaan sam-
pel di Laboratorium Prodia dan Showa University Tokyo, Jepang.
Pemeriksaan dilakukan pada trimester 1, 2 dan 2 minggu pasca-
salin. Selama kehamilan subjek penelitian diberikan susu suplemen-
tasi yang beredar di pasaran dan susu suplementasi kehamilan yang
telah difortifikasi retinol. Analisis bivariat dan multivariat dila-
kukan dengan pemberian susu retinol, kadar RBP, kadar faktor
angiogenik sebagai variabel bebas dan preeklampsia sebagai va-
riabel tergantung.
Hasil: Didapatkan 104 subjek penelitian dengan 55 orang
kelompok kontrol dan 49 orang kelompok perlakuan. Kejadian
preeklampsia pada penelitian ini sebesar 8,7% di mana 8 orang
(14,5%) dari kelompok kontrol dan 1 orang (2%) berasal dari
kelompok perlakuan. Karakteristik kedua kelompok perlakuan
adalah setara. Didapatkan kadar RBP pada kelompok perlakuan le-
bih rendah dari kelompok kontrol. Sedangkan kadar RBP pada
preeklampsia lebih tinggi daripada kelompok tidak preeklampsia.
Korelasi kadar RBP dengan faktor angiogenik tidak menunjukkan
hubungan bermakna kecuali kadar PlGF (p=0,036) tetapi memiliki
korelasi lemah (r=0,206). Kadar faktor angiogenik pada kelompok
perlakuan menunjukkan hasil lebih rendah dari kelompok kontrol
sedangkan pada preeklampsia hasil kadar faktor angiogenik selalu
lebih tinggi dibandingkan tidak preeklampsia. Dengan analisis mul-
tivariat didapatkan faktor yang berhubungan bermakna dengan
preeklampsia adalah kadar sFlt-1 (p=0,004) dan rasio sFlt-1/PlGF
(p=0,017).
Kesimpulan: Pemberian susu suplementasi retinol dapat menu-
runkan kadar RBP, menurunkan kadar faktor antiangiogenik tetapi
tidak meningkatkan kadar proangiogenik secara bermakna. Dengan
asumsi proses angiogenesis berjalan baik maka pemberian susu for-
tifikasi retinol dapat mengurangi kejadian preeklampsia. Walaupun
demikian diperlukan penelitian lanjutan dengan skala lebih besar.
[Maj Obstet Ginekol Indones 2011; 35-3:100-4]
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Angiogenesis is the process of blood vessel forma-
tion that involves a lot of factors, one of which is the
angiogenic factors.4-7 Angiogenic factors that play a
role in angiogenesis are antiangiogenic factors soluble
Endoglin (sEng), soluble Fms-like Tyrosine Kinase
Receptor-1 (sFlt-1), and proangiogenic factor Placen-
tal Growth Factor (PlGF).8 Levine et al stated that
preeclamptic patients had increased antiangiogenic
factor sFlt-1 and sEng, with a decrease of PlGF
proangiogenic factor compared with normal.8
Angiogenesis is a complex process in which the
process is largely determined by nutritional status.9-10
One nutrient that associates with cellular processes is
the micronutrient vitamin A, one of antioxidants that
play a role in protein synthesis, cellular differentia-
tion, and intercellular communication.11-2 Retinol it-
self affects angiogenesis during differentiation of vas-
cular smooth muscle cells (VSMC) as components of
blood vessels and neointimal formation so blood ves-
sels become larger in caliber.13 Other researchers
claim that milk has antioxidant capacity and is nega-
tively correlated with risk of hypertension.14-5
Based on this background one question arises
whether retinol-fortified milk as one of the antioxi-
dants may be used in the process of angiogenesis in
relation to prevention of preeclampsia, which requires
a study of retinol effects in the process of angiogene-
sis that occurs in the first trimester with the incidence
of preeclampsia in the second and third trimesters.
METHODS
This study was a stage II phase 3 clinical trial with
a randomized, double blind design. Research was con-
ducted at Dr. Cipto Mangunkusumo Hospital outpa-
tient clinic since January 2009 - December 2010.
Sample were analyzed in Prodia Laboratory and the
Laboratory of Showa University in Tokyo, Japan.
All pregnant women with gestational age less than
13 weeks and were willing to participate in research,
were measured for height, weight, and blood pressure
before laboratory tested for FRAP (Ferric Reducing
Ability of Plasma) to measure the antioxidant status
with a reference value of less than 900 nmol/mg pro-
tein.16
When subjects fulfilled the inclusion criteria they
were tested for angiogenic factors sFlt-1, PlGF, sEng
and Retinol Binding Protein (RBP), which is the
marker of retinol metabolism and pro-inflammatory
cytokines. Physical and laboratory examinations were
performed in each trimester of pregnancy and during
pregnancy subjects received supplementation of milk
available on the market, which has been fortified with
retinol, with a randomized distribution of subjects. If
there had been complications before reaching 20
weeks gestational age, the corresponding subject
would have been excluded from the study. Results of
this study was incidence of preeclampsia and infant
birth weight.
Collected data were analyzed with bivariate and
multivariate analysis and processed using SPSS 11.5.
RESULTS
This study managed to collect 104 subjects who were
divided into 2 groups: base on randomization the con-
trol group of 55 subjects and the treatment group of
49. Intervention was done to all subjects, the control
group received milk supplements available on the
market while the treatment group received milk ones
that had been enriched with antioxidants. Character-
istics of study subjects were as follows: subjects had
an average age of 28.9 years with 90% having middle
education level or higher. Subjects who worked only
49%. Most subjects had good nutritional status, only
14% who did not. The average gestational age reached
38 weeks, with 5% subjects having hypertension. Fe-
tal birth weight had an average of 3138 grams with
a minimum of 1500 grams and a maximum of 4200
grams. Results can be seen in Table 1.
Table 1. Characteristics of study subjects
Control Treatment
n % n %
Research Subject 55 52.9 49 47.1
Education
Low
Middle
High
 3
24
28
 5.5
43.6
50.9
 8
21
20
16.3
42.9
40.8
Job
Employed
Unemployed
30
25
54.5
45.5
21
28
42.9
57.1
Nutritional Status
Poor
Normal
Over
 9
35
11
16.4
63.6
20.0
 6
27
16
12.2
55.1
32.7
Hypertension History
Yes
No
 4
51
 7.3
92.7
 1
48
 2.0
98.0
Preeclampsia
Yes
No
 8
47
14.5
85.5
 1
48
 2.0
98.0
Age (year) 30±5 28±5
Gestation age (week) 39±2 39±2
Birth weight (gram) 3148±521 3127±451
Distribution of subjects based on control and treat-
ment groups showed no difference in characteristics
between the two groups (Chi square test p > 0.05),
which means that both groups are equal. In the end,
there were nine subjects who experienced preeclamp-
sia (8.7%), of which eight (14.5%) were in the control
group, and 1 (2%) in the treatment group. All numeri-
cal data have a normal distribution. 
To assess changes in RBP concentration ratio we
used a general linear model for repeated measures
(GLM). Results showed an increase of RBP in both
groups from the first and second trimester, with the
highest number being in the puerperium. RBP values
are under constant treatment group and control group
difference in the furthest contained in the third tri-
mester. Although RBP elevation was significantly dif-
ferent for each semester in each group (p < 0.05) but
the tendency of increasing ratio between control and
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treatment groups did not differ significantly (p =
0.138). Results can be seen in Figure 1.
Analysis of the relationship between RBP changes
with changes in angiogenic factors was done with the
parametric Pearson correlation test because the data
had a normal distribution. The result was that only
PlGF in both groups showed significant correlation
with RBP (p=0.036), although the correlation was
very weak (r=0.206).
Result analysis of changes in angiogenic factor
from each trimester using GLM analysis showed a
significant increase in each trimester consecutively.
Comparison of trend changes in treatment and con-
trol groups also showed significant differences. The
sFlt-1 and sEng in the treatment group were always
lower than the control group, and the concentration
of PlGF in the treatment group was lower in the first
trimester, while higher in the second and third trimes-
ter. Results can be seen in Figure 2. Changes can also
be seen in angiogenic factors level based on pree-
clampsia. In each trimester which showed a signifi-
cant increase respectively. By using the same analy-
sis, trend changes in preeclamptic and non preeclamp-
tic group also showed significant differences, which
were the higher level of sFlt-1 and sEng in preeclamp-
tic group and the changes of PlGF which was lower
in the preeclampsia group at the beginning, but higher
in the third trimester. The results can be seen in
Figure 3.
The changing relationship of RBP to preeclampsia
showed a significant difference of RBP in preeclamp-
sia and nor preeclamptic group, which can be seen in
Figure 4.
Figure 3. Graphic changes in angiogenic factor value based on the incidence of preeclampsia in each trimester
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Figure 4. RBP changes trends based on the incidence of
preeclampsia in each trimester
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Figure 2. Trend changes in angiogenic factor sEng, sFlt-1 and P1GF in the control and treatment groups in each trimester
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Figure 1. Trend changes in RBP each trimester in both groups
based on treatment
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Multivariate analysis was performed to assess the
relationship of all factors (antioxidants-milk intake,
RBP changes, and changes in angiogenic factors) and
preeclampsia by using a multiple logistic regression.
Factors that influence preeclampsia were sFlt-1 and
ratio of sFlt-1/PlGF. One unit increase in sFlt-1
biomarker would increase the risk of preeclampsia by
1.029, whereas one unit reduction of Flt-1/PlGF ratio
would reduce the risk of preeclampsia, eventhough
the Odd ratio was very small (p<0.001). The relation-
ship between levels of RBP with preeclampsia did not
show significant results and milk supplementation in
this analysis also showed no significant results.
DISCUSSION
This study aims to assess the role of micronutrients,
especially vitamin A nutrition in the prevention of
preeclampsia. The results showed that there was no
significantly different characteristics in both groups,
which meant that characteristics of both groups was
similar. In Table 1, it appears that most research sub-
jects were on average reproductive age, had a level
of middle and high education, mostly unemployed;
and had normal nutritional status with no history of
hypertension. All research subjects routenely under-
went antenatal care, met the nutritional intake and
reached an average gestational age of 38 with an
average birth weight 3318 grams. From this data can
be viewed as equal subjects of research. Results also
showed that subjects with milk supplementation reach
full term gestational age. Suggesting that good prena-
tal care, balanced lifestyle, and good pregnancy im-
prove the course of pregnancy.
Same result were also shown in Table 1 in which
among subjects who had provision of retinol-fortified
milk, only 2% had preeclampsia, compared to 14.5%
in subjects with additional food.
These results suggest that preeclampsia is a disease
in pregnancy with an unknown cause, affected by
various factors. It seems that preeclampsia can still
occur even after milk supplementation. In the treat-
ment group, which had vitamin A fortification, it can
be seen that preeclampsia only occured in 2% of sub-
jects; indicating initial hypothesis according to which
retinol will improve the process of angiogenesis is the
result of placental preeclampsia, 2%. Assuming there
is no problem in the angiogenesis process. Based on
the pathophysiology of angiogenesis, the results are
consistent with the opinion of Miano et al about the
role of retinol in vascular smooth muscle differentia-
tion.13
Regarding the RBP concentration ratio based on
the treatment as shown in Figure 1, indicating that
retinol binding protein (RBP) was increased mainly
in the control group, explained that with the fortifi-
cation of retinol that would last series of the process
from the metabolism of vitamin A, retinol will bind
RBP and retinol transport will last well, where the
end result can be assumed that the process of angio-
genesis will be formed adequately. It seems that in
addition of being a retinol transport protein, RBP also
act as inflammatory marker as stated by Vaisbuch et
al, thus enabling it has a possible biomarker for pre-
eclampsia.17 Combining many theories of preeclamp-
sia, this study showed that with provisions of micro-
nutrients and antioxidants, inflammation processes
and endothelial dysfunction that occur in preeclampsia
would be reduced and placentation process would go.
The correlation between RBP and angiogenic fac-
tors showed that RBP didn’t strongly correlate with
angiogenic factors. RBP only showed a significant as-
sociation with proangiogenic factor PlGF, although it
was weak, while its correlation with other angiogenic
didn’t show a significant relationship. Analysis of this
study suggested that RBP didn’t show any activity of
angiogenesis instead it was a retinol transport that
suspected to improve angiogenesis.
These results indirectly show the presence of po-
tential angiogenesis of vitamin A. Because the meta-
bolism of vitamin A in pregnant women is still not
fully understood, these results still needs further re-
search.18 Although the results are not very satisfactory
but from this process, we can see the role of vitamin
A in angiogenesis.
Correlation between levels of angiogenic factors in
both groups in each trimester can be seen in Figure
2. The results of this study showed that levels of an-
tiangiogenic factor, sFlt-1 and sEng in the treatment
group were always lower than the control group at
each trimester. On the countrary PlGF were always
lower in the treatment group compared to control
group. These results suggest that supplementation
with retinol fortified milk reduce the concentration of
antiangiogenic factors but not increase the levels of
proangiogenic factor. From the results we can also
see that fortified milk decreased the levels of an-
tiangiogenic factors but did not increase the level of
proangiogenic factors. Also two suggestion can be
drawn from such result, first there are many other
factors that affect the levels of angiogenic factors and
second there’s not enough of antioxidants used.
Another thing we are able to derive from the results
is the association between angiogenic factor with
preeclampsia, as shown in Figure 3. The results of
this study indicate that the concentration of antiangio-
genic factor, sFlt-1 and sEng in preeclampsia group
were always higher than the non preeclampsia group
on each trimester. Although the concentration of
proangiogenic factor PlGF in early trimester was
lower in preeclampsia, but in the third trimester PlGF
showed an agreement a higher level than the non pre-
eclampsia group. The results are concordant with
studies conducted by Levine et al and Karumanchi et
al who stated that there was an increased angiogenic
factors sFlt-1 and sEng as well as a decrease PlGF.5,8
These results show that the levels of pro and an-
tiangiogenic factors have a role in the pathophysiol-
ogy of preeclampsia, in which the concentration of
antiangiogenic factor was higher in preeclampsia
group while proangiogenic factor PlGF, was lower in
the first trimester. This shows that preeclampsia is a
disease that occurs due to a defect of placentation,
where low proangiogenic factor showed that the proc-
ess of angiogenesic was not adequate.5,8
The association between angiogenic factors and
preeclampsia was shown by the levels of angiogenic
factors that correlated with preeclampsia. It was shown
that the levels of pro and antiangiogenic factors had
a role in the pathophysiology preeclampsia.4-7 Those
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results also showed that preeclampsia was a disease
which began since early gestational placentation.17-19
The association between RBP and preeclampsia
(Figure 4) showed that in preeclampsia, RBP levels
was higher than the non preeclamptic group. Accord-
ing to Sapin et al, diseases that are classified in the
"great obstetrical syndrome" such as preeclampsia and
fetal growth restriction can be associated with abnor-
mal concentrations of retinol and retinol binding pro-
tein.19 On another note, Vaisbuch et al stated that the
RBP could be used as a marker of inflammation, a
new biomarker in preeclampsia.17 This research showed
that preeclampsia was a disease of pregnancy accom-
panied by inflammatory response and systemic endo-
thelial dysfunction, resulting in a series of symptoms
usually found in preeclampsia.20-2
By using multivariate analysis, this study showed
that antiangiogenic factors had a significant associa-
tions with preeclampsia (sFlt-1 p=0.004 and sFlt-
1/PlGF ratio p=0.017). Milk supplementation and
RBP levels didn’t show a significant result. This was
probably caused by failure to fulfill one of multivari-
ate analysis statistical test requirements related to the
"Rule of Thumb", one independent variable must be
represented by 10 output. This study didn’t have an ade-
quate output to be used in multivariate analysis (only 9
people suffered preeclampsia). This means that the num-
ber of samples and outcomes are not adequate.
In a study conducted by A-Kholy et al in Egypt
(2010) it was said that the RBP and angiogenic factors
were associated with the pathogenesis and severity of
preeclampsia.18 If we take a look at the initial pro-
portions the incidence of preeclampsia in the group
with retinol fortified milk only 2% compared with the
non retinol fortified milk that reached 14.5%, which
suggested that provision of milk with antioxidants
could reduce the incidence of preeclampsia, even-
though we are not able to fully explain the detailed
process yet. Another weakness of this study was the
number of subjects that were not adequate.
The final results of this study showed that pre-
eclampsia was a disease of pregnancy that occurred
since the beginning of placentation and influenced by
both macronutrient and micronutrient. However, there
is no denial that preeclampsia is a multifactorial dis-
ease with a cause that needs further studies.
CONCLUSION
This study can conclude and recommend that provid-
ing milk supplements can reduce levels of retinol
(RBP), and antiangiogenic factors, but does not sig-
nificantly increase proangiogenic levels. Assuming
there is no problem with process of angiogenesis the
provision of retinol-fortified milk can reduce the in-
cidence of preeclampsia. However, further research
with a larger scale is needed.
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